

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.47172361 |
| 2 | positive regulation of prostaglandin secretion (GO:0032308) | 5.75424082 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 5.64872000 |
| 4 | histone arginine methylation (GO:0034969) | 4.85260905 |
| 5 | viral transcription (GO:0019083) | 4.72728449 |
| 6 | translational termination (GO:0006415) | 4.58007348 |
| 7 | regulation of prostaglandin secretion (GO:0032306) | 4.53075064 |
| 8 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.46073189 |
| 9 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.40098157 |
| 10 | regulation of mitochondrial translation (GO:0070129) | 4.35793628 |
| 11 | DNA strand elongation (GO:0022616) | 4.21918909 |
| 12 | protein targeting to mitochondrion (GO:0006626) | 4.20214063 |
| 13 | ribosomal small subunit biogenesis (GO:0042274) | 4.18322259 |
| 14 | translational elongation (GO:0006414) | 4.14374769 |
| 15 | ATP synthesis coupled proton transport (GO:0015986) | 4.09834747 |
| 16 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.09834747 |
| 17 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.09749906 |
| 18 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.09425049 |
| 19 | base-excision repair, AP site formation (GO:0006285) | 4.07667305 |
| 20 | GDP-mannose metabolic process (GO:0019673) | 4.06019799 |
| 21 | cotranslational protein targeting to membrane (GO:0006613) | 3.99721545 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.98362744 |
| 23 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.97929783 |
| 24 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.97929783 |
| 25 | NADH dehydrogenase complex assembly (GO:0010257) | 3.97929783 |
| 26 | protein targeting to ER (GO:0045047) | 3.97452071 |
| 27 | establishment of protein localization to mitochondrion (GO:0072655) | 3.95981149 |
| 28 | maturation of SSU-rRNA (GO:0030490) | 3.93403319 |
| 29 | proteasome assembly (GO:0043248) | 3.92369367 |
| 30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.90985938 |
| 31 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.85544647 |
| 32 | telomere maintenance via recombination (GO:0000722) | 3.85062921 |
| 33 | protein complex biogenesis (GO:0070271) | 3.84593703 |
| 34 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.80757503 |
| 35 | protein localization to endoplasmic reticulum (GO:0070972) | 3.79328161 |
| 36 | DNA replication initiation (GO:0006270) | 3.78310926 |
| 37 | chaperone-mediated protein transport (GO:0072321) | 3.76237182 |
| 38 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.76016061 |
| 39 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.73990056 |
| 40 | translational initiation (GO:0006413) | 3.73582132 |
| 41 | viral life cycle (GO:0019058) | 3.65837557 |
| 42 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.64177955 |
| 43 | protein localization to mitochondrion (GO:0070585) | 3.60609548 |
| 44 | ribosomal large subunit biogenesis (GO:0042273) | 3.53995436 |
| 45 | cellular protein complex disassembly (GO:0043624) | 3.52819924 |
| 46 | peptidyl-histidine modification (GO:0018202) | 3.52539840 |
| 47 | oxidative phosphorylation (GO:0006119) | 3.52364221 |
| 48 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.50796216 |
| 49 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.50796216 |
| 50 | positive regulation of icosanoid secretion (GO:0032305) | 3.50211142 |
| 51 | formation of translation preinitiation complex (GO:0001731) | 3.45207844 |
| 52 | deoxyribose phosphate catabolic process (GO:0046386) | 3.44045970 |
| 53 | peptidyl-arginine methylation (GO:0018216) | 3.38356090 |
| 54 | peptidyl-arginine N-methylation (GO:0035246) | 3.38356090 |
| 55 | mitotic recombination (GO:0006312) | 3.36992953 |
| 56 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.33457106 |
| 57 | telomere maintenance via telomere lengthening (GO:0010833) | 3.33052731 |
| 58 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.29959358 |
| 59 | pseudouridine synthesis (GO:0001522) | 3.27785120 |
| 60 | respiratory chain complex IV assembly (GO:0008535) | 3.27532172 |
| 61 | DNA replication checkpoint (GO:0000076) | 3.27522945 |
| 62 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.25193068 |
| 63 | L-serine metabolic process (GO:0006563) | 3.24667709 |
| 64 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.24109227 |
| 65 | translation (GO:0006412) | 3.20357924 |
| 66 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.19476566 |
| 67 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.18182822 |
| 68 | respiratory electron transport chain (GO:0022904) | 3.17787688 |
| 69 | cytochrome complex assembly (GO:0017004) | 3.16280066 |
| 70 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.15695963 |
| 71 | protein complex disassembly (GO:0043241) | 3.13932989 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.13702317 |
| 73 | electron transport chain (GO:0022900) | 3.13181263 |
| 74 | positive regulation of fatty acid transport (GO:2000193) | 3.11691917 |
| 75 | inner mitochondrial membrane organization (GO:0007007) | 3.11340977 |
| 76 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.09717460 |
| 77 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.09717460 |
| 78 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.06133261 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.05526343 |
| 80 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.03269234 |
| 81 | termination of RNA polymerase III transcription (GO:0006386) | 3.03269234 |
| 82 | rRNA processing (GO:0006364) | 3.03228847 |
| 83 | CTP metabolic process (GO:0046036) | 3.01660623 |
| 84 | CTP biosynthetic process (GO:0006241) | 3.01660623 |
| 85 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.01135024 |
| 86 | negative regulation of ligase activity (GO:0051352) | 3.01135024 |
| 87 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.00547952 |
| 88 | protein neddylation (GO:0045116) | 3.00353470 |
| 89 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.98798889 |
| 90 | ribosome biogenesis (GO:0042254) | 2.98285744 |
| 91 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.98051372 |
| 92 | spliceosomal snRNP assembly (GO:0000387) | 2.98013747 |
| 93 | macromolecular complex disassembly (GO:0032984) | 2.97989182 |
| 94 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.95721724 |
| 95 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.94753841 |
| 96 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.94690999 |
| 97 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.94407224 |
| 98 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.94407224 |
| 99 | DNA unwinding involved in DNA replication (GO:0006268) | 2.93927750 |
| 100 | transcription from mitochondrial promoter (GO:0006390) | 2.93801667 |
| 101 | sequestering of actin monomers (GO:0042989) | 2.93794040 |
| 102 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.93240289 |
| 103 | establishment of integrated proviral latency (GO:0075713) | 2.92925143 |
| 104 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.92426532 |
| 105 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.91823395 |
| 106 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.91823395 |
| 107 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.91823395 |
| 108 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.91203493 |
| 109 | rRNA metabolic process (GO:0016072) | 2.90785084 |
| 110 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.89941837 |
| 111 | mitochondrial transport (GO:0006839) | 2.89350141 |
| 112 | rRNA transcription (GO:0009303) | 2.89174232 |
| 113 | response to interferon-beta (GO:0035456) | 2.87260788 |
| 114 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.86204373 |
| 115 | CENP-A containing nucleosome assembly (GO:0034080) | 2.86086548 |
| 116 | rRNA modification (GO:0000154) | 2.85775208 |
| 117 | metallo-sulfur cluster assembly (GO:0031163) | 2.85436065 |
| 118 | iron-sulfur cluster assembly (GO:0016226) | 2.85436065 |
| 119 | mRNA catabolic process (GO:0006402) | 2.81980735 |
| 120 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.81699461 |
| 121 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.81699461 |
| 122 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.81368994 |
| 123 | base-excision repair (GO:0006284) | 2.80983838 |
| 124 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.79934091 |
| 125 | tRNA modification (GO:0006400) | 2.79879940 |
| 126 | release of cytochrome c from mitochondria (GO:0001836) | 2.78913941 |
| 127 | tRNA processing (GO:0008033) | 2.78703103 |
| 128 | DNA damage response, detection of DNA damage (GO:0042769) | 2.77429166 |
| 129 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.77056024 |
| 130 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.76795622 |
| 131 | cellular component biogenesis (GO:0044085) | 2.76461065 |
| 132 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.76119243 |
| 133 | cullin deneddylation (GO:0010388) | 2.76109232 |
| 134 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.75675904 |
| 135 | chromatin remodeling at centromere (GO:0031055) | 2.75541487 |
| 136 | IMP biosynthetic process (GO:0006188) | 2.75367294 |
| 137 | mitochondrial fusion (GO:0008053) | 2.75128839 |
| 138 | RNA catabolic process (GO:0006401) | 2.74727760 |
| 139 | ubiquinone biosynthetic process (GO:0006744) | 2.74494810 |
| 140 | nucleobase biosynthetic process (GO:0046112) | 2.74113018 |
| 141 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.73525564 |
| 142 | GTP biosynthetic process (GO:0006183) | 2.73172426 |
| 143 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.69434408 |
| 144 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65693728 |
| 145 | establishment of viral latency (GO:0019043) | 2.64709193 |
| 146 | viral mRNA export from host cell nucleus (GO:0046784) | 2.64245096 |
| 147 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.63899699 |
| 148 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.63519067 |
| 149 | cell cycle G1/S phase transition (GO:0044843) | 2.63519067 |
| 150 | purine-containing compound salvage (GO:0043101) | 2.60259591 |
| 151 | protein targeting to membrane (GO:0006612) | 2.58447084 |
| 152 | regulation of protein heterodimerization activity (GO:0043497) | 2.57610113 |
| 153 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.56664973 |
| 154 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.56557510 |
| 155 | 7-methylguanosine mRNA capping (GO:0006370) | 2.55744278 |
| 156 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.55221896 |
| 157 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.55221896 |
| 158 | deoxyribonucleotide catabolic process (GO:0009264) | 2.52703391 |
| 159 | positive regulation of ligase activity (GO:0051351) | 2.52624608 |
| 160 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.52519591 |
| 161 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.52519591 |
| 162 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.52399733 |
| 163 | DNA replication-independent nucleosome organization (GO:0034724) | 2.52399733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.74869118 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.92559417 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.74619983 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.00813271 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.00016463 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.93415362 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.86044412 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.85384615 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.77587741 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.73885924 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.58876129 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.56788437 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.48333521 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.47240953 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.43556954 |
| 16 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.43242298 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.37656755 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.35637422 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.28032233 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.25757666 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.23254484 |
| 22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17724758 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10732712 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.03564575 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01789527 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.01529440 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.96024430 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.95926263 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91510511 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.90752083 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.89651322 |
| 32 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.86669570 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.85078166 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84473690 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82978842 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.80331709 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77377605 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.76216533 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72158253 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70635537 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.69797996 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69504276 |
| 43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.69379026 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.66247429 |
| 45 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.66036666 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65091882 |
| 47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64368684 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63006365 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60100057 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59773905 |
| 51 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.58695985 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56499397 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53898407 |
| 54 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53773917 |
| 55 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.50863392 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.47134382 |
| 57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.46470713 |
| 58 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.44137465 |
| 59 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.40310083 |
| 60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.40222994 |
| 61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38920245 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38451331 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.36576458 |
| 64 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.36040518 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.35506171 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34152403 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33901332 |
| 68 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33454005 |
| 69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33170806 |
| 70 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32988734 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32823920 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.32572336 |
| 73 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32345475 |
| 74 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.32006624 |
| 75 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.31961766 |
| 76 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.30828755 |
| 77 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27633061 |
| 78 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.26860285 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26143098 |
| 80 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.25950417 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25855941 |
| 82 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24039773 |
| 83 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23960622 |
| 84 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23460868 |
| 85 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.22664523 |
| 86 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.22515239 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.19646203 |
| 88 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.19394484 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18051665 |
| 90 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17021489 |
| 91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16225135 |
| 92 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15972824 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15972523 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15483318 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14331551 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14017815 |
| 97 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11698753 |
| 98 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11344216 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11142529 |
| 100 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11054691 |
| 101 | MAF_26560356_Chip-Seq_TH1_Human | 1.09582790 |
| 102 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09076061 |
| 103 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08985412 |
| 104 | MYB_26560356_Chip-Seq_TH2_Human | 1.07773173 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07632202 |
| 106 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07547655 |
| 107 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.06708168 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05659523 |
| 109 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05383916 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.03665434 |
| 111 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03295616 |
| 112 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02281984 |
| 113 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.02048619 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01411312 |
| 115 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01266517 |
| 116 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01214757 |
| 117 | MYB_26560356_Chip-Seq_TH1_Human | 1.00893668 |
| 118 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00742374 |
| 119 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00370841 |
| 120 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00193474 |
| 121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99633509 |
| 122 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99110391 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98078855 |
| 124 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.97333026 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97243897 |
| 126 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.96288485 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96122542 |
| 128 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95320018 |
| 129 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.95067467 |
| 130 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.94664507 |
| 131 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.94523359 |
| 132 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94234844 |
| 133 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93979881 |
| 134 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93960143 |
| 135 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93619450 |
| 136 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93040077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.59374691 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.41422359 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.08096266 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 2.81647826 |
| 5 | MP0005671_abnormal_response_to | 2.79028164 |
| 6 | MP0003077_abnormal_cell_cycle | 2.77353639 |
| 7 | MP0009785_altered_susceptibility_to | 2.69469795 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.65893057 |
| 9 | MP0000685_abnormal_immune_system | 2.65892972 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.61071993 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.55957500 |
| 12 | MP0008057_abnormal_DNA_replication | 2.55819192 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.55548526 |
| 14 | MP0008058_abnormal_DNA_repair | 2.37235659 |
| 15 | MP0002398_abnormal_bone_marrow | 2.21889639 |
| 16 | MP0008007_abnormal_cellular_replicative | 2.20725861 |
| 17 | MP0000490_abnormal_crypts_of | 2.18641749 |
| 18 | MP0003436_decreased_susceptibility_to | 2.18057426 |
| 19 | MP0000537_abnormal_urethra_morphology | 2.17847325 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.16271552 |
| 21 | MP0005025_abnormal_response_to | 2.16217845 |
| 22 | MP0001800_abnormal_humoral_immune | 2.11895782 |
| 23 | MP0002132_abnormal_respiratory_system | 2.05469526 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.04136565 |
| 25 | MP0002723_abnormal_immune_serum | 2.03469028 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.02958858 |
| 27 | MP0001819_abnormal_immune_cell | 2.02823368 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.99654730 |
| 29 | MP0000689_abnormal_spleen_morphology | 1.97419403 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.95233275 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.95233275 |
| 32 | MP0008789_abnormal_olfactory_epithelium | 1.93562588 |
| 33 | MP0008872_abnormal_physiological_respon | 1.91349432 |
| 34 | MP0002722_abnormal_immune_system | 1.91106950 |
| 35 | MP0002822_catalepsy | 1.89225651 |
| 36 | MP0005499_abnormal_olfactory_system | 1.87824750 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.87824750 |
| 38 | MP0000716_abnormal_immune_system | 1.87016092 |
| 39 | MP0004858_abnormal_nervous_system | 1.86279641 |
| 40 | MP0004133_heterotaxia | 1.82890171 |
| 41 | MP0002429_abnormal_blood_cell | 1.78828855 |
| 42 | MP0002405_respiratory_system_inflammati | 1.77627785 |
| 43 | MP0003186_abnormal_redox_activity | 1.77313541 |
| 44 | MP0001853_heart_inflammation | 1.77093918 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.76146881 |
| 46 | MP0002419_abnormal_innate_immunity | 1.73658912 |
| 47 | MP0006082_CNS_inflammation | 1.73656024 |
| 48 | MP0001188_hyperpigmentation | 1.70195754 |
| 49 | MP0001790_abnormal_immune_system | 1.69166839 |
| 50 | MP0005387_immune_system_phenotype | 1.69166839 |
| 51 | MP0005360_urolithiasis | 1.65656208 |
| 52 | MP0003724_increased_susceptibility_to | 1.65164923 |
| 53 | MP0008932_abnormal_embryonic_tissue | 1.60786423 |
| 54 | MP0002254_reproductive_system_inflammat | 1.59824980 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.59501592 |
| 56 | MP0003283_abnormal_digestive_organ | 1.58946614 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.58558182 |
| 58 | MP0005083_abnormal_biliary_tract | 1.58282701 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.56705120 |
| 60 | MP0002736_abnormal_nociception_after | 1.55807217 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.55799036 |
| 62 | MP0002102_abnormal_ear_morphology | 1.54633366 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.54342641 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.52020765 |
| 65 | MP0002006_tumorigenesis | 1.49289987 |
| 66 | MP0009764_decreased_sensitivity_to | 1.47047145 |
| 67 | MP0000858_altered_metastatic_potential | 1.46774550 |
| 68 | MP0003119_abnormal_digestive_system | 1.44618387 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.43804459 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.43465588 |
| 71 | MP0006054_spinal_hemorrhage | 1.39785195 |
| 72 | MP0000313_abnormal_cell_death | 1.38499723 |
| 73 | MP0000372_irregular_coat_pigmentation | 1.38386403 |
| 74 | MP0002938_white_spotting | 1.36664391 |
| 75 | MP0000049_abnormal_middle_ear | 1.34855546 |
| 76 | MP0004147_increased_porphyrin_level | 1.34546049 |
| 77 | MP0003786_premature_aging | 1.33958863 |
| 78 | MP0005670_abnormal_white_adipose | 1.33175168 |
| 79 | MP0005174_abnormal_tail_pigmentation | 1.32642653 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30578568 |
| 81 | MP0000350_abnormal_cell_proliferation | 1.26473973 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.26153162 |
| 83 | MP0002653_abnormal_ependyma_morphology | 1.25511484 |
| 84 | MP0001873_stomach_inflammation | 1.25225980 |
| 85 | MP0006276_abnormal_autonomic_nervous | 1.23986764 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.18684456 |
| 87 | MP0000538_abnormal_urinary_bladder | 1.18332284 |
| 88 | MP0010030_abnormal_orbit_morphology | 1.18081570 |
| 89 | MP0002638_abnormal_pupillary_reflex | 1.17326636 |
| 90 | MP0002160_abnormal_reproductive_system | 1.15176933 |
| 91 | MP0003121_genomic_imprinting | 1.13140448 |
| 92 | MP0003646_muscle_fatigue | 1.10175458 |
| 93 | MP0008469_abnormal_protein_level | 1.09235707 |
| 94 | MP0001293_anophthalmia | 1.09193580 |
| 95 | MP0001727_abnormal_embryo_implantation | 1.08383528 |
| 96 | MP0005410_abnormal_fertilization | 1.07416534 |
| 97 | MP0003866_abnormal_defecation | 1.06898455 |
| 98 | MP0001730_embryonic_growth_arrest | 1.05967302 |
| 99 | MP0003137_abnormal_impulse_conducting | 1.03392890 |
| 100 | MP0009379_abnormal_foot_pigmentation | 1.03099044 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 1.02293986 |
| 102 | MP0005645_abnormal_hypothalamus_physiol | 1.02004852 |
| 103 | MP0009278_abnormal_bone_marrow | 1.00585185 |
| 104 | MP0003567_abnormal_fetal_cardiomyocyte | 1.00158190 |
| 105 | MP0010307_abnormal_tumor_latency | 0.96028079 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.95841318 |
| 107 | MP0008995_early_reproductive_senescence | 0.93408647 |
| 108 | MP0001968_abnormal_touch/_nociception | 0.93145867 |
| 109 | MP0003123_paternal_imprinting | 0.92416511 |
| 110 | MP0000358_abnormal_cell_content/ | 0.91451360 |
| 111 | MP0005451_abnormal_body_composition | 0.91057159 |
| 112 | MP0000516_abnormal_urinary_system | 0.90882214 |
| 113 | MP0005367_renal/urinary_system_phenotyp | 0.90882214 |
| 114 | MP0002139_abnormal_hepatobiliary_system | 0.90727739 |
| 115 | MP0002095_abnormal_skin_pigmentation | 0.90717595 |
| 116 | MP0008877_abnormal_DNA_methylation | 0.87652624 |
| 117 | MP0004947_skin_inflammation | 0.87578888 |
| 118 | MP0003718_maternal_effect | 0.86517978 |
| 119 | MP0001929_abnormal_gametogenesis | 0.86119178 |
| 120 | MP0005332_abnormal_amino_acid | 0.84746557 |
| 121 | MP0002080_prenatal_lethality | 0.83779191 |
| 122 | MP0003448_altered_tumor_morphology | 0.81966341 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.81937548 |
| 124 | MP0004019_abnormal_vitamin_homeostasis | 0.81046768 |
| 125 | MP0003698_abnormal_male_reproductive | 0.80970040 |
| 126 | MP0001919_abnormal_reproductive_system | 0.80946336 |
| 127 | MP0005310_abnormal_salivary_gland | 0.80611189 |
| 128 | MP0000653_abnormal_sex_gland | 0.80204497 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80058170 |
| 130 | MP0000015_abnormal_ear_pigmentation | 0.79667078 |
| 131 | MP0005084_abnormal_gallbladder_morpholo | 0.79080810 |
| 132 | MP0000343_altered_response_to | 0.78703583 |
| 133 | MP0001533_abnormal_skeleton_physiology | 0.77715058 |
| 134 | MP0002111_abnormal_tail_morphology | 0.77610914 |
| 135 | MP0001986_abnormal_taste_sensitivity | 0.77236316 |
| 136 | MP0003136_yellow_coat_color | 0.76988721 |
| 137 | MP0003787_abnormal_imprinting | 0.76752420 |
| 138 | MP0001905_abnormal_dopamine_level | 0.75755695 |
| 139 | MP0005636_abnormal_mineral_homeostasis | 0.75540566 |
| 140 | MP0002933_joint_inflammation | 0.74828697 |
| 141 | MP0006292_abnormal_olfactory_placode | 0.74218773 |
| 142 | MP0001529_abnormal_vocalization | 0.73567454 |
| 143 | MP0005389_reproductive_system_phenotype | 0.73546254 |
| 144 | MP0002085_abnormal_embryonic_tissue | 0.72632431 |
| 145 | MP0005381_digestive/alimentary_phenotyp | 0.71276078 |
| 146 | MP0001984_abnormal_olfaction | 0.71081337 |
| 147 | MP0002876_abnormal_thyroid_physiology | 0.70969917 |
| 148 | MP0001697_abnormal_embryo_size | 0.70863233 |
| 149 | MP0002210_abnormal_sex_determination | 0.70579057 |
| 150 | MP0000631_abnormal_neuroendocrine_gland | 0.70062475 |
| 151 | MP0008770_decreased_survivor_rate | 0.69941806 |
| 152 | MP0003122_maternal_imprinting | 0.69810751 |
| 153 | MP0000462_abnormal_digestive_system | 0.69267582 |
| 154 | MP0008260_abnormal_autophagy | 0.69158222 |
| 155 | MP0006035_abnormal_mitochondrial_morpho | 0.66198153 |
| 156 | MP0001764_abnormal_homeostasis | 0.65888943 |
| 157 | MP0009840_abnormal_foam_cell | 0.64535297 |
| 158 | MP0000477_abnormal_intestine_morphology | 0.64176390 |
| 159 | MP0001119_abnormal_female_reproductive | 0.63876770 |
| 160 | MP0001145_abnormal_male_reproductive | 0.60965010 |
| 161 | MP0003315_abnormal_perineum_morphology | 0.59431976 |
| 162 | MP0001663_abnormal_digestive_system | 0.59068564 |
| 163 | MP0002163_abnormal_gland_morphology | 0.58646434 |
| 164 | MP0008873_increased_physiological_sensi | 0.57956239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.99809235 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.96744285 |
| 3 | Reticulocytopenia (HP:0001896) | 4.30384406 |
| 4 | Aplastic anemia (HP:0001915) | 4.17948352 |
| 5 | Acute encephalopathy (HP:0006846) | 4.15572627 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.09468363 |
| 7 | Thrombocytosis (HP:0001894) | 3.60287753 |
| 8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.56278088 |
| 9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.56278088 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.43362307 |
| 11 | Birth length less than 3rd percentile (HP:0003561) | 3.30458813 |
| 12 | Pallor (HP:0000980) | 3.30143578 |
| 13 | IgM deficiency (HP:0002850) | 3.29600895 |
| 14 | Hyperglycinemia (HP:0002154) | 3.28194653 |
| 15 | Lactic acidosis (HP:0003128) | 3.18597178 |
| 16 | Petechiae (HP:0000967) | 3.18028395 |
| 17 | Type II lissencephaly (HP:0007260) | 3.17164906 |
| 18 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.16717417 |
| 19 | Oral leukoplakia (HP:0002745) | 3.15846594 |
| 20 | Cerebral edema (HP:0002181) | 3.09482202 |
| 21 | Progressive macrocephaly (HP:0004481) | 3.07029666 |
| 22 | Type I transferrin isoform profile (HP:0003642) | 3.04439846 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 3.03066251 |
| 24 | Macrocytic anemia (HP:0001972) | 3.00626813 |
| 25 | Hypoplasia of the pons (HP:0012110) | 2.99105243 |
| 26 | Hyperglycinuria (HP:0003108) | 2.93526466 |
| 27 | Poor head control (HP:0002421) | 2.88803676 |
| 28 | Chronic otitis media (HP:0000389) | 2.88618164 |
| 29 | Myositis (HP:0100614) | 2.86827772 |
| 30 | Exertional dyspnea (HP:0002875) | 2.86608924 |
| 31 | Cerebellar dysplasia (HP:0007033) | 2.84977839 |
| 32 | Microvesicular hepatic steatosis (HP:0001414) | 2.79382247 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.75128283 |
| 34 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.69775517 |
| 35 | Microretrognathia (HP:0000308) | 2.67939914 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 2.64140864 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.63342207 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.60554755 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.59914123 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.59914123 |
| 41 | Reduced antithrombin III activity (HP:0001976) | 2.59769178 |
| 42 | Pancytopenia (HP:0001876) | 2.58930262 |
| 43 | IgG deficiency (HP:0004315) | 2.58104126 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 2.57192911 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57192911 |
| 46 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.56996022 |
| 47 | Abnormality of T cells (HP:0002843) | 2.54520599 |
| 48 | Abnormality of the pons (HP:0007361) | 2.53469578 |
| 49 | Muscle fiber atrophy (HP:0100295) | 2.48404513 |
| 50 | Respiratory failure (HP:0002878) | 2.47948821 |
| 51 | Increased hepatocellular lipid droplets (HP:0006565) | 2.47923576 |
| 52 | Agnosia (HP:0010524) | 2.46625244 |
| 53 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.44719990 |
| 54 | Lymphoma (HP:0002665) | 2.43770885 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.43126181 |
| 56 | Type 2 muscle fiber atrophy (HP:0003554) | 2.43032187 |
| 57 | Cerebral hypomyelination (HP:0006808) | 2.42526921 |
| 58 | Abnormal protein glycosylation (HP:0012346) | 2.42152731 |
| 59 | Abnormal glycosylation (HP:0012345) | 2.42152731 |
| 60 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.42152731 |
| 61 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.42152731 |
| 62 | Increased serum lactate (HP:0002151) | 2.41406083 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.38081806 |
| 64 | Rough bone trabeculation (HP:0100670) | 2.36934633 |
| 65 | Abnormal trabecular bone morphology (HP:0100671) | 2.36804211 |
| 66 | Recurrent viral infections (HP:0004429) | 2.36178470 |
| 67 | Leukodystrophy (HP:0002415) | 2.35378589 |
| 68 | Premature graying of hair (HP:0002216) | 2.34049485 |
| 69 | Increased intramyocellular lipid droplets (HP:0012240) | 2.31075575 |
| 70 | Mitochondrial inheritance (HP:0001427) | 2.31059688 |
| 71 | Exercise intolerance (HP:0003546) | 2.30683748 |
| 72 | Eczematoid dermatitis (HP:0000976) | 2.29571734 |
| 73 | Horseshoe kidney (HP:0000085) | 2.29283667 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.29125569 |
| 75 | Recurrent skin infections (HP:0001581) | 2.28328786 |
| 76 | Severe combined immunodeficiency (HP:0004430) | 2.27213111 |
| 77 | Bone marrow hypocellularity (HP:0005528) | 2.26151147 |
| 78 | Hepatic necrosis (HP:0002605) | 2.23394693 |
| 79 | Recurrent fungal infections (HP:0002841) | 2.22596789 |
| 80 | Methylmalonic aciduria (HP:0012120) | 2.21833188 |
| 81 | Lethargy (HP:0001254) | 2.21678599 |
| 82 | Abnormality of the anterior horn cell (HP:0006802) | 2.20331998 |
| 83 | Degeneration of anterior horn cells (HP:0002398) | 2.20331998 |
| 84 | Pulmonary fibrosis (HP:0002206) | 2.19469134 |
| 85 | Lipid accumulation in hepatocytes (HP:0006561) | 2.17246161 |
| 86 | Cerebral palsy (HP:0100021) | 2.16892710 |
| 87 | Breast hypoplasia (HP:0003187) | 2.16850029 |
| 88 | 11 pairs of ribs (HP:0000878) | 2.16759123 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.15391044 |
| 90 | Shoulder girdle muscle weakness (HP:0003547) | 2.14410421 |
| 91 | Asplenia (HP:0001746) | 2.13553801 |
| 92 | Abnormality of urine glucose concentration (HP:0011016) | 2.13033315 |
| 93 | Glycosuria (HP:0003076) | 2.13033315 |
| 94 | Increased IgM level (HP:0003496) | 2.11070866 |
| 95 | Respiratory difficulties (HP:0002880) | 2.10665714 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10197011 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10197011 |
| 98 | Ragged-red muscle fibers (HP:0003200) | 2.09550586 |
| 99 | Myelodysplasia (HP:0002863) | 2.06774191 |
| 100 | Short femoral neck (HP:0100864) | 2.04558862 |
| 101 | Increased CSF lactate (HP:0002490) | 2.03775754 |
| 102 | Renal Fanconi syndrome (HP:0001994) | 2.01439593 |
| 103 | Nasal polyposis (HP:0100582) | 2.00290921 |
| 104 | Meningitis (HP:0001287) | 1.99500278 |
| 105 | Retinal dysplasia (HP:0007973) | 1.98591748 |
| 106 | Absent thumb (HP:0009777) | 1.98565051 |
| 107 | Pustule (HP:0200039) | 1.97446467 |
| 108 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.97083614 |
| 109 | Hypoplasia of the brainstem (HP:0002365) | 1.97083614 |
| 110 | Obstructive lung disease (HP:0006536) | 1.97066862 |
| 111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97066862 |
| 112 | Increased muscle lipid content (HP:0009058) | 1.96556503 |
| 113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96548709 |
| 114 | Lissencephaly (HP:0001339) | 1.96472011 |
| 115 | Lymphopenia (HP:0001888) | 1.95441800 |
| 116 | Carpal bone hypoplasia (HP:0001498) | 1.95429526 |
| 117 | Optic nerve coloboma (HP:0000588) | 1.93234270 |
| 118 | Cellular immunodeficiency (HP:0005374) | 1.92854022 |
| 119 | Colon cancer (HP:0003003) | 1.92188830 |
| 120 | Prolonged bleeding time (HP:0003010) | 1.91723254 |
| 121 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.91487325 |
| 122 | Hyperammonemia (HP:0001987) | 1.91413745 |
| 123 | Selective tooth agenesis (HP:0001592) | 1.90369365 |
| 124 | CNS demyelination (HP:0007305) | 1.90221418 |
| 125 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.89352278 |
| 126 | Neutropenia (HP:0001875) | 1.89080709 |
| 127 | Multiple enchondromatosis (HP:0005701) | 1.89035677 |
| 128 | T lymphocytopenia (HP:0005403) | 1.88721407 |
| 129 | Optic disc pallor (HP:0000543) | 1.87817195 |
| 130 | Increased serum ferritin (HP:0003281) | 1.86960589 |
| 131 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.86515412 |
| 132 | Abnormality of serum amino acid levels (HP:0003112) | 1.85827122 |
| 133 | Chromsome breakage (HP:0040012) | 1.85511420 |
| 134 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.85270795 |
| 135 | Amaurosis fugax (HP:0100576) | 1.84696196 |
| 136 | Severe muscular hypotonia (HP:0006829) | 1.84691962 |
| 137 | Abnormality of reticulocytes (HP:0004312) | 1.84618991 |
| 138 | Opisthotonus (HP:0002179) | 1.84491981 |
| 139 | Nausea (HP:0002018) | 1.83859244 |
| 140 | Acute necrotizing encephalopathy (HP:0006965) | 1.83798490 |
| 141 | Emotional lability (HP:0000712) | 1.83390508 |
| 142 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.82548456 |
| 143 | Abnormality of alanine metabolism (HP:0010916) | 1.78314642 |
| 144 | Hyperalaninemia (HP:0003348) | 1.78314642 |
| 145 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78314642 |
| 146 | Myopathic facies (HP:0002058) | 1.77831944 |
| 147 | Cerebellar hypoplasia (HP:0001321) | 1.75822388 |
| 148 | Impulsivity (HP:0100710) | 1.73714401 |
| 149 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.72028339 |
| 150 | Anomalous pulmonary venous return (HP:0010772) | 1.70095167 |
| 151 | Increased serum pyruvate (HP:0003542) | 1.69641301 |
| 152 | Cleft eyelid (HP:0000625) | 1.68163809 |
| 153 | Abnormality of the labia minora (HP:0012880) | 1.67055063 |
| 154 | Pendular nystagmus (HP:0012043) | 1.65078315 |
| 155 | Congenital malformation of the right heart (HP:0011723) | 1.62979667 |
| 156 | Double outlet right ventricle (HP:0001719) | 1.62979667 |
| 157 | Blindness (HP:0000618) | 1.62863028 |
| 158 | Neoplasm of the pancreas (HP:0002894) | 1.61851072 |
| 159 | Patellar aplasia (HP:0006443) | 1.61082344 |
| 160 | Abnormality of glycolysis (HP:0004366) | 1.59200600 |
| 161 | Myokymia (HP:0002411) | 1.57988735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K7 | 5.98586955 |
| 2 | MAP3K4 | 4.93918385 |
| 3 | VRK2 | 3.53660194 |
| 4 | BUB1 | 3.52743088 |
| 5 | NME2 | 3.52433173 |
| 6 | ZAK | 3.52269179 |
| 7 | TESK2 | 3.24969106 |
| 8 | MAP2K4 | 2.90073637 |
| 9 | WEE1 | 2.86475832 |
| 10 | MAP4K1 | 2.82055514 |
| 11 | STK16 | 2.66055974 |
| 12 | PIM2 | 2.60271550 |
| 13 | EIF2AK1 | 2.35089676 |
| 14 | VRK1 | 2.11427229 |
| 15 | CDC7 | 2.06765800 |
| 16 | ACVR1B | 2.04031699 |
| 17 | BLK | 1.96827181 |
| 18 | TLK1 | 1.87956083 |
| 19 | EIF2AK3 | 1.84314993 |
| 20 | KDR | 1.84304756 |
| 21 | KIT | 1.74577476 |
| 22 | DYRK3 | 1.72848769 |
| 23 | IRAK4 | 1.71772475 |
| 24 | SRPK1 | 1.67956861 |
| 25 | TXK | 1.64275871 |
| 26 | PASK | 1.59470073 |
| 27 | TBK1 | 1.59329965 |
| 28 | BTK | 1.58334881 |
| 29 | MAP3K11 | 1.57819543 |
| 30 | CSNK1G3 | 1.49829914 |
| 31 | ZAP70 | 1.46641103 |
| 32 | RPS6KA4 | 1.36415306 |
| 33 | TEC | 1.35884235 |
| 34 | TESK1 | 1.35693315 |
| 35 | SMG1 | 1.34414924 |
| 36 | FLT3 | 1.33024800 |
| 37 | BRSK2 | 1.27378679 |
| 38 | NEK2 | 1.26416536 |
| 39 | SCYL2 | 1.24731966 |
| 40 | CSNK1G2 | 1.24279124 |
| 41 | PLK4 | 1.24055405 |
| 42 | TYK2 | 1.22820801 |
| 43 | JAK3 | 1.21589334 |
| 44 | PIM1 | 1.20845412 |
| 45 | CDK7 | 1.20198513 |
| 46 | IKBKE | 1.18690232 |
| 47 | CLK1 | 1.18464625 |
| 48 | CSNK1A1L | 1.15971947 |
| 49 | STK10 | 1.13912029 |
| 50 | PLK1 | 1.11199146 |
| 51 | PAK4 | 1.10141401 |
| 52 | CDK8 | 1.09931092 |
| 53 | CSF1R | 1.05122460 |
| 54 | IKBKB | 1.04819172 |
| 55 | CSNK1G1 | 1.03747210 |
| 56 | ATR | 1.03668876 |
| 57 | MKNK1 | 1.00068507 |
| 58 | SYK | 0.99510276 |
| 59 | MAP3K12 | 0.98993683 |
| 60 | CDK19 | 0.97636524 |
| 61 | RPS6KB2 | 0.95791330 |
| 62 | PBK | 0.93911989 |
| 63 | AURKB | 0.93570527 |
| 64 | MAP3K8 | 0.93302989 |
| 65 | LIMK1 | 0.92896926 |
| 66 | ARAF | 0.92673763 |
| 67 | TAF1 | 0.91976904 |
| 68 | GRK6 | 0.90792906 |
| 69 | LYN | 0.88608574 |
| 70 | LRRK2 | 0.88467387 |
| 71 | SIK3 | 0.87857530 |
| 72 | TGFBR1 | 0.86637420 |
| 73 | PDK2 | 0.86034217 |
| 74 | PRKCI | 0.85447104 |
| 75 | BRSK1 | 0.84912706 |
| 76 | NLK | 0.84107676 |
| 77 | TSSK6 | 0.83512345 |
| 78 | AURKA | 0.82779304 |
| 79 | STK4 | 0.80835886 |
| 80 | TRIB3 | 0.80410269 |
| 81 | MATK | 0.80035909 |
| 82 | MAPKAPK3 | 0.79915696 |
| 83 | ERN1 | 0.79698311 |
| 84 | NUAK1 | 0.79366917 |
| 85 | NME1 | 0.79364802 |
| 86 | BCKDK | 0.78873891 |
| 87 | MAP4K2 | 0.77456547 |
| 88 | CDK4 | 0.76989368 |
| 89 | EPHB2 | 0.74971015 |
| 90 | MAP2K3 | 0.74910331 |
| 91 | CCNB1 | 0.74477452 |
| 92 | CASK | 0.71806230 |
| 93 | MAP3K14 | 0.71463507 |
| 94 | IRAK3 | 0.70662212 |
| 95 | LCK | 0.69276436 |
| 96 | RPS6KA5 | 0.69031302 |
| 97 | ABL2 | 0.68880771 |
| 98 | TAOK2 | 0.66491073 |
| 99 | BRAF | 0.64929788 |
| 100 | MAP2K2 | 0.63161914 |
| 101 | CHEK2 | 0.62623071 |
| 102 | DAPK1 | 0.61560471 |
| 103 | RAF1 | 0.61530725 |
| 104 | EEF2K | 0.61167971 |
| 105 | MAPK13 | 0.61130766 |
| 106 | PAK1 | 0.59722217 |
| 107 | ILK | 0.56563363 |
| 108 | TTK | 0.56360081 |
| 109 | MAP3K10 | 0.55789045 |
| 110 | CSNK2A1 | 0.54308222 |
| 111 | NEK1 | 0.52699742 |
| 112 | MKNK2 | 0.52188869 |
| 113 | DYRK2 | 0.48946263 |
| 114 | PKN1 | 0.48443015 |
| 115 | EIF2AK2 | 0.47542327 |
| 116 | MUSK | 0.46426574 |
| 117 | RPS6KA6 | 0.46091254 |
| 118 | CSNK2A2 | 0.45150881 |
| 119 | ADRBK2 | 0.43681538 |
| 120 | DAPK3 | 0.43451257 |
| 121 | ITK | 0.42883357 |
| 122 | MAPKAPK5 | 0.41125391 |
| 123 | MAPK11 | 0.40695536 |
| 124 | CHEK1 | 0.38485990 |
| 125 | AKT2 | 0.38216585 |
| 126 | RET | 0.36997258 |
| 127 | TRIM28 | 0.36787374 |
| 128 | LMTK2 | 0.35790722 |
| 129 | OXSR1 | 0.34352370 |
| 130 | CSNK1A1 | 0.34158607 |
| 131 | CDK11A | 0.32961704 |
| 132 | WNK3 | 0.32885381 |
| 133 | GRK1 | 0.29822281 |
| 134 | PLK3 | 0.24619073 |
| 135 | DYRK1B | 0.24172109 |
| 136 | CDK2 | 0.23422830 |
| 137 | CDK14 | 0.21424778 |
| 138 | RPS6KA1 | 0.20882627 |
| 139 | BMX | 0.20393513 |
| 140 | PRKCZ | 0.19728194 |
| 141 | ATM | 0.17724010 |
| 142 | CDK15 | 0.17472519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.64642008 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.35065527 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.63220081 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.54013348 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.18550737 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 3.04530422 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.64797778 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.57933906 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.54414460 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.51067205 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.44347961 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34764286 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.28816476 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.15656100 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.89949117 |
| 16 | RNA transport_Homo sapiens_hsa03013 | 1.84299089 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73882216 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 1.73524142 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.66663622 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.56085088 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54568782 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.52898491 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.51841196 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.48857375 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.48115427 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.47471998 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46328596 |
| 28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.38041559 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34451338 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28478094 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.28176598 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.27231060 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26649209 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26227796 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25517347 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23617767 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22736616 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22623303 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.22069614 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.20738148 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20048306 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16556179 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16349252 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.16235794 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14419558 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14221377 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.12816808 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12288079 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12070865 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11681603 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.10039475 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09392424 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.09314785 |
| 54 | Alcoholism_Homo sapiens_hsa05034 | 1.07862374 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02165688 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.00617661 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00442315 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98890509 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98796973 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98236742 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95438897 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.95200868 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93703243 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.93197170 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93029494 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90293432 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87592969 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.83769228 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77931650 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.76590546 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76306069 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76263354 |
| 73 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.76048824 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75483331 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.72514964 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71543784 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70691832 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70673012 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70586220 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69815095 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69356569 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69192984 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68866564 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67975910 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66935111 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62881879 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.61790445 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60933105 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60404198 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59729027 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59504270 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.59270394 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.57878073 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57456011 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57395737 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55817736 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.55423510 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54633741 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52906134 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51946977 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51713870 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51531250 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51280831 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50996642 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50377802 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48480173 |
| 107 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48071752 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.46828373 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44595915 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43874036 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43188679 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43166641 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42129965 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41964827 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41725793 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41471985 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.41078347 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40964313 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40013610 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38364433 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37724311 |
| 122 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36215158 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35827877 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35342793 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34099067 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31451920 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31352875 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30395945 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30317934 |
| 130 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.29532244 |
| 131 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29177386 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29051998 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27178637 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.27087901 |
| 135 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26994761 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.26597831 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26013009 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25475243 |
| 139 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24643259 |
| 140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24621944 |
| 141 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24525273 |
| 142 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23941202 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.22917827 |
| 144 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.22290044 |
| 145 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.19079817 |

